Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

Respiratory chain complex I is a mitochondrial tumor suppressor of oncocytic tumors.

Zimmermann FA, Mayr JA, Feichtinger R, Neureiter D, Lechner R, Koegler C, Ratschek M, Rusmir H, Sargsyan K, Sperl W, Kofler B.

Front Biosci (Elite Ed). 2011 Jan 1;3:315-25. Review.

PMID:
21196312
2.

Mitochondrial complex I is deficient in renal oncocytomas.

Simonnet H, Demont J, Pfeiffer K, Guenaneche L, Bouvier R, Brandt U, Schagger H, Godinot C.

Carcinogenesis. 2003 Sep;24(9):1461-6. Epub 2003 Jul 4.

PMID:
12844484
3.

Defective oxidative phosphorylation in thyroid oncocytic carcinoma is associated with pathogenic mitochondrial DNA mutations affecting complexes I and III.

Bonora E, Porcelli AM, Gasparre G, Biondi A, Ghelli A, Carelli V, Baracca A, Tallini G, Martinuzzi A, Lenaz G, Rugolo M, Romeo G.

Cancer Res. 2006 Jun 15;66(12):6087-96.

4.

Clonal expansion of mutated mitochondrial DNA is associated with tumor formation and complex I deficiency in the benign renal oncocytoma.

Gasparre G, Hervouet E, de Laplanche E, Demont J, Pennisi LF, Colombel M, Mège-Lechevallier F, Scoazec JY, Bonora E, Smeets R, Smeitink J, Lazar V, Lespinasse J, Giraud S, Godinot C, Romeo G, Simonnet H.

Hum Mol Genet. 2008 Apr 1;17(7):986-95. Epub 2007 Dec 21.

PMID:
18156159
5.

Loss of complex I due to mitochondrial DNA mutations in renal oncocytoma.

Mayr JA, Meierhofer D, Zimmermann F, Feichtinger R, Kögler C, Ratschek M, Schmeller N, Sperl W, Kofler B.

Clin Cancer Res. 2008 Apr 15;14(8):2270-5. doi: 10.1158/1078-0432.CCR-07-4131.

6.

PGC-1-related coactivator and targets are upregulated in thyroid oncocytoma.

Savagner F, Mirebeau D, Jacques C, Guyetant S, Morgan C, Franc B, Reynier P, Malthièry Y.

Biochem Biophys Res Commun. 2003 Oct 24;310(3):779-84.

PMID:
14550271
7.

Restoration of mitochondrial function in cells with complex I deficiency.

Bai Y, Park JS, Deng JH, Li Y, Hu P.

Ann N Y Acad Sci. 2005 May;1042:25-35.

PMID:
15965042
8.

Proteome and cytoskeleton responses in osteosarcoma cells with reduced OXPHOS activity.

Annunen-Rasila J, Ohlmeier S, Tuokko H, Veijola J, Majamaa K.

Proteomics. 2007 Jun;7(13):2189-200.

PMID:
17533645
9.

Low mitochondrial respiratory chain content correlates with tumor aggressiveness in renal cell carcinoma.

Simonnet H, Alazard N, Pfeiffer K, Gallou C, Béroud C, Demont J, Bouvier R, Schägger H, Godinot C.

Carcinogenesis. 2002 May;23(5):759-68.

PMID:
12016148
10.

Transcriptional profiling reveals coordinated up-regulation of oxidative metabolism genes in thyroid oncocytic tumors.

Baris O, Savagner F, Nasser V, Loriod B, Granjeaud S, Guyetant S, Franc B, Rodien P, Rohmer V, Bertucci F, Birnbaum D, Malthièry Y, Reynier P, Houlgatte R.

J Clin Endocrinol Metab. 2004 Feb;89(2):994-1005.

PMID:
14764826
11.

Heterogeneity of mitochondrial energy metabolism in classical triphasic Wilms' tumor.

Feichtinger RG, Neureiter D, Royer-Pokora B, Mayr JA, Zimmermann FA, Jones N, Koegler C, Ratschek M, Sperl W, Kofler B.

Front Biosci (Elite Ed). 2011 Jan 1;3:187-93.

PMID:
21196297
12.
13.

Mitochondrial DNA mutations distinguish bilateral multifocal renal oncocytomas from familial Birt-Hogg-Dubé tumors.

Lang M, Vocke CD, Merino MJ, Schmidt LS, Linehan WM.

Mod Pathol. 2015 Nov;28(11):1458-69. doi: 10.1038/modpathol.2015.101. Epub 2015 Oct 2.

14.

Differences in assembly or stability of complex I and other mitochondrial OXPHOS complexes in inherited complex I deficiency.

Ugalde C, Janssen RJ, van den Heuvel LP, Smeitink JA, Nijtmans LG.

Hum Mol Genet. 2004 Mar 15;13(6):659-67. Epub 2004 Jan 28.

PMID:
14749350
15.

Molecular and metabolic features of oncocytomas: Seeking the blueprints of indolent cancers.

De Luise M, Girolimetti G, Okere B, Porcelli AM, Kurelac I, Gasparre G.

Biochim Biophys Acta. 2017 Aug;1858(8):591-601. doi: 10.1016/j.bbabio.2017.01.009. Epub 2017 Jan 20. Review.

PMID:
28115060
16.

A mutation screening of oncogenes, tumor suppressor gene TP53 and nuclear encoded mitochondrial complex I genes in oncocytic thyroid tumors.

Evangelisti C, de Biase D, Kurelac I, Ceccarelli C, Prokisch H, Meitinger T, Caria P, Vanni R, Romeo G, Tallini G, Gasparre G, Bonora E.

BMC Cancer. 2015 Mar 21;15:157. doi: 10.1186/s12885-015-1122-3.

17.

Adrenocortical oncocytic tumors: report of 10 cases and review of the literature.

Bisceglia M, Ludovico O, Di Mattia A, Ben-Dor D, Sandbank J, Pasquinelli G, Lau SK, Weiss LM.

Int J Surg Pathol. 2004 Jul;12(3):231-43.

PMID:
15306935
18.

An inherited mitochondrial DNA disruptive mutation shifts to homoplasmy in oncocytic tumor cells.

Gasparre G, Iommarini L, Porcelli AM, Lang M, Ferri GG, Kurelac I, Zuntini R, Mariani E, Pennisi LF, Pasquini E, Pasquinelli G, Ghelli A, Bonora E, Ceccarelli C, Rugolo M, Salfi N, Romeo G, Carelli V.

Hum Mutat. 2009 Mar;30(3):391-6. doi: 10.1002/humu.20870.

PMID:
19086058
19.

Gene expression profiling implicates OXPHOS complexes in lifespan extension of flies over-expressing a small mitochondrial chaperone, Hsp22.

Kim HJ, Morrow G, Westwood JT, Michaud S, Tanguay RM.

Exp Gerontol. 2010 Aug;45(7-8):611-20. doi: 10.1016/j.exger.2009.12.012. Epub 2009 Dec 29.

PMID:
20036725
20.

Defective mitochondrial ATP synthesis in oxyphilic thyroid tumors.

Savagner F, Franc B, Guyetant S, Rodien P, Reynier P, Malthiery Y.

J Clin Endocrinol Metab. 2001 Oct;86(10):4920-5.

PMID:
11600563

Supplemental Content

Support Center